Diabetic Cardiomyopathy

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 2006 English Publisher:Elsevier BVJournal:Endocrinology and Metabolism Clinics of North America, volume 35, pages 575-599 (issn: 0889-8529,

Authors: Gregg C, Fonarow; Preethi, Srikanthan;

doi: 10.1016/j.ecl.2006.05.003

pmid: 16959587

Diabetic Cardiomyopathy

- Summary
- Subjects
- Metrics

Abstract

This article focuses on advances in the understanding of the pathogenesis and treatment of diabetic cardiomyopathy. Patients with diabetes are at an elevated risk for heart failure, and comorbid heart failure confers an increased risk of morbidity and mortality. Diabetic cardiomyopathy and to apply proven lifesaving therapies in all heart failure patients, including those with diabetes, in the absence of contraindications or intolerance.

Related Organizations

University of California, Los Angeles
United States

Keywords

Diabetes Complications, PPAR gamma, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Risk Factors, Humans, Thiazolidinediones, Cardiomyopathies, Diabetic Angiopathies, Mineralocorticoid Receptor Antagonists

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	57
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%